Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02476526 · ClinicalTrials.gov registry record · Phase 4
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
A Phase 4 study, sponsored by VA Greater Los Angeles Healthcare System.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT02476526 is a Phase 4 study that has completed, run by VA Greater Los Angeles Healthcare System. The registered enrollment target is 50 participants.
The verdict
NCT02476526, a Phase 4 study, has completed, sponsored by VA Greater Los Angeles Healthcare System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to show that the use of low volume iso-osmolar non-ionic radio contrast medium (30 cc) in a thoracic CT Scanning procedure in a selected group of patients with chronic kidney disease (CKD) will avoid contrast induced nephropathy (CIN) in comparison to a similar group of patients with CKD who receive no contrast medium..
Interventions
- DRUG Low Volume iso-osmolar non-ionic radio contrast medium
- DRUG Acetylcysteine Inhalation
- DRUG Sodium Bicarbonate Solution
- PROCEDURE 64-MDCT Scanning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-09 |
| Est. Completion | 2017-11-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02476526
The ClinicalTrials.gov registry entry for NCT02476526 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Greater Los Angeles Healthcare System, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Low Volume iso-osmolar non-ionic radio contrast medium is the first listed.
NCT02476526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02476526 about?
NCT02476526 is a clinical study titled "Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease". The purpose of this study is to show that the use of low volume iso-osmolar non-ionic radio contrast medium (30 cc) in a thoracic CT Scanning procedure in a selected group of patients with chronic kidney disease (CKD) will avoid contrast induced nephropathy (CIN) in comparison to a similar group of ...
What is the current status of trial NCT02476526?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2008-09. Estimated completion is 2017-11-20.
What interventions are being tested in trial NCT02476526?
The interventions under investigation include: Low Volume iso-osmolar non-ionic radio contrast medium (DRUG), Acetylcysteine Inhalation (DRUG), Sodium Bicarbonate Solution (DRUG), 64-MDCT Scanning (PROCEDURE).
Who is sponsoring clinical trial NCT02476526?
This trial is sponsored by VA Greater Los Angeles Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.